COLL vs VRTX · P/E 17, rev $181.9M vs P/E 30, rev $12.00B
Collegium Pharmaceutical Inc (COLL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the COLL and VRTX stock pages for the full models.
Not investment advice.